All companies
Visit website
CALIBRE BIOMETRICS
OperatingCalibre Biometrics Inc.
Healthcare · Technology · Founded 2022
Revolutionizing breath measurement through ultralight wearable device
Post-money valuation ⓘ
$22.8M
As of Mar 2023 · from Calibre Biometrics Class A Common Stock 1 · pre-money + amount raised, not a traded price
Total raised
$58,887
Across 1 round since 2023
Latest share price
$2.50
Calibre Biometrics Class A Common Stock 1 offering price
Financials
FY2020–FY2021 · from SEC filings · hover any figure for its source$0
−$475K
2020
$0
−$1.8M
2021
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$475,411
-$1,753,269
Taxes paid
$0
$0
Balance sheet
Cash
$19,054
$431,447
Accounts receivable
$0
$0
Total assets
$19,054
$439,915
Short-term debt
$91
$329,808
Long-term debt
$0
$450,000
Total liabilities
$91
$779,808
Other
Headcount
—
5
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$22.8M
post-money
Calibre Biometrics Class A Common Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $58.9K / $1.2MInvestors 32Post-money $22.8M
Reg CF annual-report compliance
Delinquent
Filed 0 of 4 annual reports (FY2022–FY2025)
Missing: 2022, 2023, 2024, 2025
32 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001897609Share price $2.50
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.